Skip to main content
  • Original article
  • Open access
  • Published:

Serum retinol-binding protein 4 and the risk of ischemic stroke in Egyptian patients with hypothyroidism

Abstract

Objective

Ischemic stroke (IS) is one of the major causes of disability and death worldwide. Effective prevention remains the best approach to reduce the burden of stroke. Adipokines can serve as a key messenger to central energy homeostasis and metabolic homeostasis. Retinol-binding protein 4 (RBP4), a retinol transporter, is elevated in insulin resistance. Controversy exists regarding the role of RBP4 in thyroid diseases. The objective of this study was to evaluate serum RBP4 in patients with hypothyroidism and to assess the association of serum RBP4 with susceptibility of IS.

Patients and methods

This case–control study included 50 healthy individuals as a control group and 90 patients with hypothyroidism, who were stratified into two subgroups: patients with IS and patients without IS. All participants were subjected to history taking and clinical, laboratory, and radiological evaluation.

Results

Serum RBP4 levels were significantly higher in hypothyroid patient, especially patients with IS, compared with the nonstroke group. Interestingly, serum RBP4 level was positively correlated with vascular and metabolic risk factors. Moreover, diastolic and systolic blood pressures, triglyceride, free T3, as well as thyroid-stimulating hormone, were independently correlated with serum RBP4 by linear regression analysis test. The diagnostic power of serum RBP4 level in differentiating hypothyroidism from controls was revealed at the cutoff value of 12.25, with area under the curve of 0.909 (95% confidence interval: 0.861–0.957). However, the diagnostic power of serum RBP4 level in differentiating hypothyroid patient with IS from those without stroke was revealed at the cutoff values of 11.4, with area under the curve of 0.822 (95% confidence interval: 0.737–0.906). In conclusion, the higher levels of serum RBP4 in hypothyroidism, especially in patients with IS, were associated with metabolic and glucose abnormalities, and thus, it could be used as a promising predictive biomarker of IS in hypothyroidism.

References

  1. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJM, Holman RR. UKPDS 59: Hyperglycemia b and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002; 25:894–899.

    Article  Google Scholar 

  2. Bunevicius A, Iervasi G, Bunevicius R. Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert Rev Neurother 2015; 15:315–326.

    Article  CAS  Google Scholar 

  3. Chaker L, Baumgartner C, Ikram MA, Dehghan A, Medici M, Visser WE, et al. Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis. Eur J Epidemiol 2014; 29:791–800.

    Article  CAS  Google Scholar 

  4. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 1999; 19:1004–1009.

    Article  CAS  Google Scholar 

  5. Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 1989; 10:308–316.

    Article  CAS  Google Scholar 

  6. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436:356–362.

    Article  CAS  Google Scholar 

  7. Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354:2552–2563.

    Article  CAS  Google Scholar 

  8. Deng W, Zhang Y, Zheng Y, Jiang Y, Wu Q, Liang Z, et al. Serum retinol-binding protein 4 levels are elevated but do not contribute to insulin resistance in newly diagnosed Chinese hypertensive patients. Diabetol Metab Syndr 2014; 6:72.

    Article  Google Scholar 

  9. Zhang JX, Zhu GP, Zhang BL, Cheng YY. Elevated serum retinol-binding protein 4 levels are correlated with blood pressure in prehypertensive Chinese. J Hum Hypertens 2017; 31:611–615.

    Article  CAS  Google Scholar 

  10. Bobbert P, Weithäuser A, Andres J, Bobbert T, Kühl U, Schultheiss HP, et al. Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy. Eur J Heart Fail. 2009; 11:1163–1168.

    Article  CAS  Google Scholar 

  11. Chavarria N, Kato TS, Khan R, Chokshi A, Collado E, Akashi H, et al. Increased levels of retinol-binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement. Circ J 2012; 76:2148–2152.

    Article  CAS  Google Scholar 

  12. Bobbert T, Raila J, Schwarz F, Mai K, Henze A, Pfeiffer AF, et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima-media thickness. Atherosclerosis 2010; 213:549–551.

    Article  CAS  Google Scholar 

  13. Mohapatra J, Sharma M, Acharya A, Pandya G, Chatterjee A, Balaraman R, Jain MR. Retinol-binding protein 4: a possible role in cardiovascular complications. Br J Pharmacol 2011; 164:1939–1948.

    Article  CAS  Google Scholar 

  14. Zemany L, Bhanot S, Peroni OD, Murray SF, Moraes-Vieira PM, Castoldi A, et al. Transthyretin antisense oligonucleotides lower circulating RBP4 levels and improve insulin sensitivity in obese mice. Diabetes 2015; 64:1603–1614.

    Article  CAS  Google Scholar 

  15. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373:2103–2116.

    CAS  PubMed  Google Scholar 

  16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499–502.

    Article  CAS  Google Scholar 

  17. Murphy J. Pharmacological treatment of acute ischemic stroke. Crit Care Nurs Q 2003; 26:276–282.

    Article  Google Scholar 

  18. Sun Q, Kiernan UA, Shi L, Phillips DA, Kahn BB, Hu FB, et al. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses’ health study. Circulation 2013; 127:1938–1947.

    Article  CAS  Google Scholar 

  19. Li F, Xia K, Sheikh MS, Cheng J, Li C, Yang T. Retinol binding protein 4 promotes the hyperinsulinism-induced proliferation of rat aortic smooth muscle cells. Mol Med Rep 2014; 9:1634–1640.

    Article  CAS  Google Scholar 

  20. Liu Y, Zhong Y, Chen H, Wang D, Wang M, Ou JS, Xia M. Retinol-bindingprotein-dependent cholesterol uptake regulates macrophage foam cell formation and promotes atherosclerosis. Circulation 2017; 135:1339–1354.

    Article  CAS  Google Scholar 

  21. Lambadiari V, Kadoglou NP, Stasinos V, Maratou E, Antoniadis A, Kolokathis F, et al. Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease. Cardiovasc Diabetol 2014; 13:121.

    Article  Google Scholar 

  22. Liu Y, Wang D, Chen H, Xia M. Circulating retinol binding protein 4 is associated with coronary lesion severity of patients with coronary artery disease. Atherosclerosis 2015; 238:45–51.

    Article  CAS  Google Scholar 

  23. Mallat Z, Simon T, Benessiano J, Clément K, Taleb S, Wareham NJ, et al. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab 2009; 94:255–260.

    Article  CAS  Google Scholar 

  24. Wang H, Zhou P, Zou D, Liu Y, Lu X, Liu Z. The role of retinol-binding protein 4 and its relationship with sex hormones in coronary artery disease. Biochem Biophys Res Commun 2018; 506:204–210.

    Article  CAS  Google Scholar 

  25. Choi SH, Lee YJ, Park YJ, Kim KW, Lee EJ, Lim S, et al. Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance. J Clin Endocrinol Metab 2008; 93:2313–2318.

    Article  CAS  Google Scholar 

  26. Kokkinos S, Papazoglou D, Zisimopoulos A, Papanas N, Tiaka E, Antonoglou C, et al. Retinol binding protein-4 and adiponectin levels in thyroid overt and subclinical dysfunction. Exp Clin Endocrinol Diabetes 2016; 124:87–92.

    CAS  PubMed  Google Scholar 

  27. Güdücü N, Görmüş U, Kavak ZN, İşçi H, Yiğiter AB, Dünder İ. Retinol-binding protein 4 is elevated and is associated with free testosterone and TSH in postmenopausal women. J Endocrinol Invest 2013; 36:831–834.

    Article  Google Scholar 

  28. Chaker L, Baumgartner C, den Elzen WPJ, Ikram MA, Blum MR, Collet TH, et al. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J Clin Endocrinol Metab 2015; 100:2181–2191.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nearmeen M. Rashad MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashad, N.M., Sabry, H.M., Afifi, S.A. et al. Serum retinol-binding protein 4 and the risk of ischemic stroke in Egyptian patients with hypothyroidism. Egypt J Intern Med 31, 746–753 (2019). https://doi.org/10.4103/ejim.ejim_131_19

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_131_19

Keywords